ENvue Medical annual shares outstanding
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
ENvue Medical Shares Outstanding History (FEED)
ENvue Medical reported 1.1M shares outstanding at the end of fiscal 2025.
View full ENvue Medical company overviewENvue Medical annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.1M | 1.1M | +2803.92% |
| 2024 | 2024-12-31 | 37,894 | −148,134 | −79.63% |
| 2023 | 2023-12-31 | 186,028 | −1.5M | −88.66% |
| 2022 | 2022-12-31 | 1.6M | 241,256 | +17.23% |
| 2021 | 2021-12-31 | 1.4M | −19.8M | −93.41% |
| 2020 | 2020-12-31 | 21.2M | 17.0M | +405.42% |
| 2019 | 2019-12-31 | 4.2M | 402,242 | +10.58% |
| 2018 | 2018-12-31 | 3.8M | −134,343 | −3.41% |
| 2017 | 2017-12-31 | 3.9M | 1.3M | +49.50% |
| 2016 | 2016-12-31 | 2.6M | 21,382 | +0.82% |
| 2015 | 2015-12-31 | 2.6M | 2.4M | +1496.36% |
| 2014 | 2014-12-31 | 163,580 | — | — |
ENvue Medical quarterly shares outstanding
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
As of Dec 3, 2020
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q1.25
Q2.25
As of Aug 11, 2025
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 8.2M | 8.2M | +81943770.00% |
| Q1 2026 | 2026-03-31 | 3.7M | 2.9M | +370.04% |
| Q4 2025 | 2025-12-31 | 1.1M | 366,388 | +49.91% |
| Q3 2025 | 2025-09-30 | 1.0M | 1.0M | +9191590.91% |
| As of Aug 11, 2025 | 2025-08-11 | 10 | −378,931 | −100.00% |
| Q2 2025 | 2025-06-30 | 787,359 | −2.0M | −71.72% |
| Q1 2025 · Mar 31 | 2025-03-31 | 734,025 | −2.1M | −73.64% |
| Q1 2025 · Mar 13 | 2025-03-13 | 11 | −2.8M | −100.00% |
| Q4 2024 | 2024-12-31 | 378,941 | −1.7M | −81.48% |
| Q3 2024 | 2024-09-30 | 2.8M | 942,022 | +51.13% |
| Q2 2024 | 2024-06-30 | 2.8M | 1.1M | +67.50% |
| Q1 2024 | 2024-03-31 | 2.8M | 1.1M | +67.50% |
| Q4 2023 | 2023-12-31 | 2.0M | 405,161 | +24.69% |
| Q3 2023 | 2023-09-30 | 1.8M | −26.2M | −93.42% |
| Q2 2023 | 2023-06-30 | 1.7M | −26.3M | −94.06% |
| Q1 2023 | 2023-03-31 | 1.7M | −26.3M | −94.06% |
| Q4 2022 | 2022-12-31 | 1.6M | −26.4M | −94.14% |
| Q3 2022 | 2022-09-30 | 28.0M | 819,667 | +3.02% |
| Q2 2022 | 2022-06-30 | 28.0M | 3.9M | +16.13% |
| Q1 2022 | 2022-03-31 | 28.0M | 3.9M | +16.13% |
| Q4 2021 | 2021-12-31 | 28.0M | 6.8M | +31.78% |
| Q3 2021 | 2021-09-30 | 27.2M | 7.3M | +36.92% |
| Q2 2021 | 2021-06-30 | 24.1M | 11.6M | +92.98% |
| Q1 2021 | 2021-03-31 | 24.1M | 19.8M | +458.90% |
| Q4 2020 | 2020-12-31 | 21.2M | 16.9M | +392.53% |
| As of Dec 3, 2020 | 2020-12-03 | 19.9M | 15.6M | +372.20% |
| Q3 2020 | 2020-09-30 | 12.5M | 8.1M | +182.03% |
| Q2 2020 | 2020-06-30 | 4.3M | 173,800 | +4.20% |
| Q1 2020 | 2020-03-31 | 4.3M | 237,242 | +5.82% |
| Q4 2019 | 2019-12-31 | 4.2M | 402,242 | +10.58% |
| Q3 2019 | 2019-09-30 | 4.4M | 462,904 | +11.67% |
| Q2 2019 | 2019-06-30 | 4.1M | 182,011 | +4.60% |
| Q1 2019 | 2019-03-31 | 4.1M | 140,657 | +3.57% |
| Q4 2018 | 2018-12-31 | 3.8M | −134,343 | −3.41% |
| Q3 2018 | 2018-09-30 | 4.0M | 1.3M | +50.68% |
| Q2 2018 | 2018-06-30 | 4.0M | 1.3M | +50.34% |
| Q1 2018 | 2018-03-31 | 3.9M | 1.3M | +49.50% |
| Q4 2017 | 2017-12-31 | 3.9M | 1.3M | +49.50% |
| Q3 2017 | 2017-09-30 | 2.6M | 0 | 0.00% |
| Q2 2017 | 2017-06-30 | 2.6M | 9,000 | +0.34% |
| Q1 2017 | 2017-03-31 | 2.6M | 9,000 | +0.34% |
| Q4 2016 | 2016-12-31 | 2.6M | 21,382 | +0.82% |
| Q3 2016 | 2016-09-30 | 2.6M | 21,382 | +0.82% |
| Q2 2016 | 2016-06-30 | 2.6M | 12,382 | +0.47% |
| Q1 2016 | 2016-03-31 | 2.6M | 2.2M | +590.00% |
| Q4 2015 | 2015-12-31 | 2.6M | 2.4M | +1496.36% |
| Q3 2015 | 2015-09-30 | 2.6M | — | — |
| Q2 2015 | 2015-06-30 | 2.6M | — | — |
| Q1 2015 | 2015-03-31 | 380,247 | — | — |
| Q4 2014 | 2014-12-31 | 163,580 | — | — |
ENvue Medical shares outstanding trends
Over the last five reported fiscal years, ENvue Medical's shares outstanding moved from 21.2M to 1.1M, a change of −20.1M. The latest reported quarter, Q2 2026, shows 8.2M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ENvue Medical filings at SEC.gov ↗